ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and AtherosclerosisjeanfrancoismaisonJun 5, 20251 min readhttps://pubmed.ncbi.nlm.nih.gov/40467521/
Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activityhttps://pubmed.ncbi.nlm.nih.gov/40450523/
Optimization of a novel 2+2 BCMA x CD3 bispecific antibody for minimized cytokine release and potent efficacyhttps://pubmed.ncbi.nlm.nih.gov/40465538/